Hermann Kreyenberg

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

Peter Bader, Hermann Kreyenberg, Günter Henze et al. · Journal of Clinical Oncology · 2008 · 358 citations · Full text

Increasing Mixed Chimerism Is an Important Prognostic Factor for Unfavorable Outcome in Children With Acute Lymphoblastic Leukemia After Allogeneic Stem-Cell Transplantation: Possible Role For Pre-Emptive Immunotherapy?

Peter Bader, Hermann Kreyenberg, W Hoelle et al. · Journal of Clinical Oncology · 2004 · 251 citations

Hematological Malignancy, Cell Therapy, Transplantation +15

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

Peter Bader, Jeremy Hancock, Hermann Kreyenberg et al. · Leukemia · 2002 · 198 citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +8

CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties

Selim Kuçi, Zyrafete Kuçi, Hermann Kreyenberg et al. · Haematologica · 2010 · 191 citations · Full text

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab

P. Schlegel, Peter Lang, Gerhard Zugmaier et al. · Haematologica · 2014 · 134 citations · Full text